Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy

Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of lipid research Jg. 58; H. 1; S. 151 - 163
Hauptverfasser: Le Dour, Caroline, Wu, Wei, Béréziat, Véronique, Capeau, Jacqueline, Vigouroux, Corinne, Worman, Howard J
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier 01.01.2017
Schlagworte:
ISSN:1539-7262, 0022-2275, 1539-7262
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alterations in the extracellular matrix of adipose tissue leading to fibrosis play a role in the pathophysiology of lipodystrophy syndromes. However, the extent of extracellular matrix alterations in FPLD2 remains unknown. We show significantly increased fibrosis and altered expression of genes encoding extracellular matrix proteins in cervical subcutaneous adipose tissue from a human subject with FLPD2. Similar extracellular matrix alterations occur in adipose tissue of transgenic mice expressing an FPLD2-causing human lamin A variant and in cultured fibroblasts from human subjects with FPLD2 and related lipodystrophies. These abnormalities are associated with increased transforming growth factor-β signaling and defects in matrix metalloproteinase 9 activity. Our data demonstrate that lamin A/C gene mutations responsible for FPLD2 and related lipodystrophies are associated with transforming growth factor-β activation and an extracellular matrix imbalance in adipose tissue, suggesting that targeting these alterations could be the basis of novel therapies.
AbstractList Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alterations in the extracellular matrix of adipose tissue leading to fibrosis play a role in the pathophysiology of lipodystrophy syndromes. However, the extent of extracellular matrix alterations in FPLD2 remains unknown. We show significantly increased fibrosis and altered expression of genes encoding extracellular matrix proteins in cervical subcutaneous adipose tissue from a human subject with FLPD2. Similar extracellular matrix alterations occur in adipose tissue of transgenic mice expressing an FPLD2-causing human lamin A variant and in cultured fibroblasts from human subjects with FPLD2 and related lipodystrophies. These abnormalities are associated with increased transforming growth factor-β signaling and defects in matrix metalloproteinase 9 activity. Our data demonstrate that lamin A/C gene mutations responsible for FPLD2 and related lipodystrophies are associated with transforming growth factor-β activation and an extracellular matrix imbalance in adipose tissue, suggesting that targeting these alterations could be the basis of novel therapies.
Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alterations in the extracellular matrix of adipose tissue leading to fibrosis play a role in the pathophysiology of lipodystrophy syndromes. However, the extent of extracellular matrix alterations in FPLD2 remains unknown. We show significantly increased fibrosis and altered expression of genes encoding extracellular matrix proteins in cervical subcutaneous adipose tissue from a human subject with FLPD2. Similar extracellular matrix alterations occur in adipose tissue of transgenic mice expressing an FPLD2-causing human lamin A variant and in cultured fibroblasts from human subjects with FPLD2 and related lipodystrophies. These abnormalities are associated with increased transforming growth factor-β signaling and defects in matrix metalloproteinase 9 activity. Our data demonstrate that lamin A/C gene mutations responsible for FPLD2 and related lipodystrophies are associated with transforming growth factor-β activation and an extracellular matrix imbalance in adipose tissue, suggesting that targeting these alterations could be the basis of novel therapies.Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alterations in the extracellular matrix of adipose tissue leading to fibrosis play a role in the pathophysiology of lipodystrophy syndromes. However, the extent of extracellular matrix alterations in FPLD2 remains unknown. We show significantly increased fibrosis and altered expression of genes encoding extracellular matrix proteins in cervical subcutaneous adipose tissue from a human subject with FLPD2. Similar extracellular matrix alterations occur in adipose tissue of transgenic mice expressing an FPLD2-causing human lamin A variant and in cultured fibroblasts from human subjects with FPLD2 and related lipodystrophies. These abnormalities are associated with increased transforming growth factor-β signaling and defects in matrix metalloproteinase 9 activity. Our data demonstrate that lamin A/C gene mutations responsible for FPLD2 and related lipodystrophies are associated with transforming growth factor-β activation and an extracellular matrix imbalance in adipose tissue, suggesting that targeting these alterations could be the basis of novel therapies.
Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy syndromes. These are mainly characterized by redistribution of adipose tissue associated with insulin resistance. Several reports suggest that alterations in the extracellular matrix of adipose tissue leading to fibrosis play a role in the pathophysiology of lipodystrophy syndromes. However, the extent of extracellular matrix alterations in FPLD2 remains unknown. We show significantly increased fibrosis and altered expression of genes encoding extracellular matrix proteins in cervical subcutaneous adipose tissue from a human subject with FLPD2. Similar extracellular matrix alterations occur in adipose tissue of transgenic mice expressing an FPLD2-causing human lamin A variant and in cultured fibroblasts from human subjects with FPLD2 and related lipodystrophies. These abnormalities are associated with increased transforming growth factor-β signaling and defects in matrix metalloproteinase 9 activity. Our data demonstrate that lamin A/C gene mutations responsible for FPLD2 and related lipodystrophies are associated with transforming growth factor-β activation and an extracellular matrix imbalance in adipose tissue, suggesting that targeting these alterations could be the basis of novel therapies
Author Wu, Wei
Vigouroux, Corinne
Capeau, Jacqueline
Le Dour, Caroline
Worman, Howard J
Béréziat, Véronique
Author_xml – sequence: 1
  givenname: Caroline
  surname: Le Dour
  fullname: Le Dour, Caroline
  organization: Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY
– sequence: 2
  givenname: Wei
  surname: Wu
  fullname: Wu, Wei
  organization: Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY
– sequence: 3
  givenname: Véronique
  surname: Béréziat
  fullname: Béréziat, Véronique
  organization: Saint-Antoine Research Center, Institute of Cardiometabolism and Nutrition, INSERM UMR, Pierre-and-Marie Curie University, Université Paris, Sorbonne Universités, Paris, France
– sequence: 4
  givenname: Jacqueline
  surname: Capeau
  fullname: Capeau, Jacqueline
  organization: Department of Biochemistry and Hormonology, Assistance Publique-Hopitaux de Paris, Hôpital Tenon, Paris, France
– sequence: 5
  givenname: Corinne
  surname: Vigouroux
  fullname: Vigouroux, Corinne
  organization: Departments of Molecular Biology and Endocrinology, Assistance Publique-Hopitaux de Paris, Hôpital Saint-Antoine, Paris, France
– sequence: 6
  givenname: Howard J
  surname: Worman
  fullname: Worman, Howard J
  email: hjw14@columbia.edu
  organization: Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27845687$$D View this record in MEDLINE/PubMed
BookMark eNpNkc1u1DAUhS1URP9YsUdesklrx3acLKtRgUpF3dB1dG3fzHiU2IPtQOcteBYepM_UlCmoq3t09N1zpXtOyVGIAQn5wNkF55283I7p4hvTXLT8DTnhSnSVrpv66JU-Jqc5bxnjUjb8HTmudStV0-oT8vv6oSSwOI7zCIlOUJJ_oAmn6HD0YU0hOLoQIQ8xTc_GOsVfZUMHsCWm6vEPzX4d4MCasECLLh4z9cHNFh01ezrCskqvLlf0JyQPoWRaNlCohTkjHf0uun0uKe42-3PydoAx4_uXeUbuP19_X32tbu--3Kyubiur2rZUlhnOmBtkI2uhnFCIuh6EYEq2ndBGNkZibdRgeKccM2hY52xrB6iROwvijNwccl2Ebb9LfoK07yP4_q8R07qHVLwdsR80R9c6ZRjTshHKKOSsU5ZZKzUMdsn6dMjapfhjxlz6yefnn0LAOOeet6LTQi8FLejHF3Q2E7r_h_81Ip4AwSWTgg
CitedBy_id crossref_primary_10_1002_adbi_202200301
crossref_primary_10_1016_j_bbadis_2018_01_025
crossref_primary_10_1016_j_jhep_2023_07_036
crossref_primary_10_1091_mbc_E18_10_0672
crossref_primary_10_1083_jcb_201701043
crossref_primary_10_3389_fcell_2025_1641584
crossref_primary_10_3389_fped_2022_1032653
crossref_primary_10_3390_cells9091947
crossref_primary_10_3390_jcm9041069
crossref_primary_10_1016_j_jbc_2022_101748
crossref_primary_10_3389_fgene_2017_00079
crossref_primary_10_1097_QAD_0000000000002168
crossref_primary_10_1080_10717544_2020_1831104
crossref_primary_10_1002_prp2_1160
crossref_primary_10_1080_01942638_2022_2158054
crossref_primary_10_3390_cancers10060199
crossref_primary_10_1210_endocr_bqad038
crossref_primary_10_1016_S1957_2557_18_30173_1
crossref_primary_10_1091_mbc_E18_07_0438
crossref_primary_10_3390_cells9030765
crossref_primary_10_1016_j_jprot_2017_08_007
crossref_primary_10_1093_hmg_ddy055
crossref_primary_10_1016_j_ceb_2017_12_009
crossref_primary_10_1093_hmg_ddz195
crossref_primary_10_3389_fcell_2018_00073
crossref_primary_10_1097_HC9_0000000000000618
crossref_primary_10_3390_jcm10214834
crossref_primary_10_1016_j_gde_2021_02_003
crossref_primary_10_1016_j_diabet_2018_08_003
crossref_primary_10_1053_j_gastro_2018_03_026
ContentType Journal Article
Copyright Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1194/jlr.M071381
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1539-7262
EndPage 163
ExternalDocumentID oai_doaj_org_article_f71ed8d5b0074635b5e1095c0cc47afc
27845687
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: R01 AR048997
GroupedDBID ---
-~X
.55
.GJ
0R~
0VX
18M
29K
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
AAEDW
AAFWJ
AALRI
AAXUO
AAYOK
ABCQX
ABOCM
ACCCW
ACGFO
ACKIV
ACNCT
ACPRK
ADBBV
ADVLN
AENEX
AEXQZ
AFFNX
AFOSN
AI.
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
HYE
H~9
J5H
KQ8
L7B
MVM
NPM
OK1
P2P
RHF
RHI
ROL
RPM
TBC
TR2
TWZ
VH1
W8F
WH7
WOQ
X7M
YHG
YKV
ZGI
ZXP
~KM
7X8
AAYWO
ACVFH
ADCNI
AEUPX
AFPKN
AFPUW
AIGII
AKBMS
AKYEP
ID FETCH-LOGICAL-c588t-c0b100df464235d35ee72f330548937b46b4e2b5fb195d0beb09dc8cfa2e1dca3
IEDL.DBID DOA
ISICitedReferencesCount 37
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000392408700012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1539-7262
0022-2275
IngestDate Fri Oct 03 12:50:56 EDT 2025
Thu Sep 04 17:34:36 EDT 2025
Thu Jan 02 22:56:52 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords adipose tissue
nuclear envelope
fibrosis
adipocytes
Language English
License Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c588t-c0b100df464235d35ee72f330548937b46b4e2b5fb195d0beb09dc8cfa2e1dca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/f71ed8d5b0074635b5e1095c0cc47afc
PMID 27845687
PQID 1839737381
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_f71ed8d5b0074635b5e1095c0cc47afc
proquest_miscellaneous_1839737381
pubmed_primary_27845687
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of lipid research
PublicationTitleAlternate J Lipid Res
PublicationYear 2017
Publisher Elsevier
Publisher_xml – name: Elsevier
SSID ssj0014461
Score 2.3827708
Snippet Mutations in the lamin A/C gene encoding nuclear lamins A and C (lamin A/C) cause familial partial lipodystrophy type 2 (FPLD2) and related lipodystrophy...
SourceID doaj
proquest
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 151
SubjectTerms adipocytes
adipose tissue
Adipose Tissue - metabolism
Adipose Tissue - pathology
Aged
Aged, 80 and over
Animals
Cell Line
Extracellular Matrix - genetics
Extracellular Matrix - metabolism
fibrosis
Gene Expression Regulation
Humans
Lamin Type A - genetics
Lipodystrophy, Familial Partial - genetics
Lipodystrophy, Familial Partial - metabolism
Lipodystrophy, Familial Partial - pathology
Male
Matrix Metalloproteinase 9 - biosynthesis
Matrix Metalloproteinase 9 - genetics
Mice
Mice, Knockout
Middle Aged
Mutation
nuclear envelope
Transforming Growth Factor beta - biosynthesis
Transforming Growth Factor beta - genetics
Title Extracellular matrix remodeling and transforming growth factor-β signaling abnormalities induced by lamin A/C variants that cause lipodystrophy
URI https://www.ncbi.nlm.nih.gov/pubmed/27845687
https://www.proquest.com/docview/1839737381
https://doaj.org/article/f71ed8d5b0074635b5e1095c0cc47afc
Volume 58
WOSCitedRecordID wos000392408700012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LatwwFBVNKCSb0iZpMn2EWwjZuSPLViQvp0NCNxmyaGF2Ri83Eyae4PGEzF_0W_oh_abeK9ulm9JNN14YI4t7hHSPdHUOY2cul4J7pKl0KzKhg5mkyCudOOcVV05VhbHRbELNZno-L27-sPqimrBOHrgL3LhSafDaSxudMTJpZUgxLXDcuVyZytHsy1UxkKn-_ABJTjrohAuhZH8zDxn7-G7ZfLwmbkZS1lGn_-_JZVxkrl6yF312CJOuV6_Ys1AfsMNJjcz4fgvnEOs140b4AdubDl5th-z75VPbGNqEp6pSuCfd_SdoQvS5wcUJTO2hHXJUevEN6Xd7C53dTvLzB1Ahh-m-tTUlssuotQrI2RF9D3YLOHgWNUzGU3hEhk0FNNDemhac2awDLBcPK7_F_qwQuSP29eryy_Rz0nstJE5q3SaO25RzX-XIRzLpMxmCElWGswGp0yibX9g8CCsrmxbScxssL7zTrjIipN6Z7DXbrVd1OGFgnLPYkLJKY3NZaoPymdAGuY8VgosR-0RRLx86OY2SBK7jC4S97GEv_wX7iH0YMCsx1hRgU4fVZl1SyqdIrykdseMOzN-_olNWeaHVm__RhbdsX9AaH_dj3rHdttmE9-y5e2wX6-aU7ai5Po2jEp-zm-tfv4DrXg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extracellular+matrix+remodeling+and+transforming+growth+factor-%CE%B2+signaling+abnormalities+induced+by+lamin+A%2FC+variants+that+cause+lipodystrophy&rft.jtitle=Journal+of+lipid+research&rft.au=Caroline+Le+Dour&rft.au=Wei+Wu&rft.au=V%C3%A9ronique+B%C3%A9r%C3%A9ziat&rft.au=Jacqueline+Capeau&rft.date=2017-01-01&rft.pub=Elsevier&rft.issn=0022-2275&rft.volume=58&rft.issue=1&rft.spage=151&rft.epage=163&rft_id=info:doi/10.1194%2Fjlr.M071381&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f71ed8d5b0074635b5e1095c0cc47afc
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1539-7262&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1539-7262&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1539-7262&client=summon